GT Biopharma (GTBP) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting of Stockholders scheduled for June 25, 2024, at 9:00 AM Pacific Time.
Stockholders are reminded to vote their shares, regardless of the number owned.
Voting can be completed via internet or telephone using the control number provided.
Voting matters and shareholder proposals
Stockholders holding 100 or more shares received a direct communication urging them to vote.
Proxy materials include instructions for voting and contact information for assistance.
Shareholder rights and capital structure
Communication emphasizes the importance of every shareholder's vote, regardless of share count.
Partial view of Summaries dataset, powered by Quartr API
Latest events from GT Biopharma
- TriKE® nanobody platform advances next-gen NK cell therapies for cancer and autoimmune disease.GTBP
Corporate presentation16 Mar 2026 - Net loss increased to $28.4M in 2025, with cash runway projected through Q4 2026.GTBP
Q4 20252 Mar 2026 - Registering 22.7M shares for resale amid financial uncertainty and Nasdaq compliance risk.GTBP
Registration Filing21 Jan 2026 - Biotech registers 625,283 shares for resale amid financial and Nasdaq compliance challenges.GTBP
Registration Filing16 Dec 2025 - Shareholder votes may enable new financing, major equity plan changes, and board refresh.GTBP
Proxy Filing2 Dec 2025 - Shareholders will vote on board elections, auditor, executive pay, major share issuances, and equity plan.GTBP
Proxy Filing2 Dec 2025 - Key votes include director elections, auditor ratification, and major share issuance approval.GTBP
Proxy Filing2 Dec 2025 - Biotech seeks $7.1M via flexible share/warrant offering amid financial and Nasdaq listing risks.GTBP
Registration Filing29 Nov 2025 - Biotech seeks flexible capital via large resale registration amid financial and Nasdaq risks.GTBP
Registration Filing29 Nov 2025